The FDA tried to call the dietary supplement industry’s bluff. It appears to have blinked.

BY CHELSEY MCINTYRE, PHARMD

Since the passage of the Dietary Supplement Health and Education Act (DSHEA) 30 years ago, the U.S. dietary supplement market has grown into a vast industry that has little in common with its DSHEA-era predecessor. Over the years, the retroactive structure of DSHEA has encouraged the influx of bad actors who have identified the dietary supplement sector as a venue for the introduction of unapproved drugs into the U.S. market.

Fill out the form to read the full article.